ライフサイエンスコーパス: influenza-like illness

1 mpared findings in those with a diagnosis of influenza like illness.

2 primary or ambulatory care with influenza or influenza-like illness.

3 tory illnesses (ARIs), which may manifest as influenza-like illness.

4 Disease Control and Prevention criteria for influenza-like illness.

5 ted to 8 healthcare facilities in Kenya with influenza-like illness.

6 during the study period who did not have an influenza-like illness.

7 to sentinel sites within 7 days of onset of influenza-like illness.

8 in respiratory secretions from a child with influenza-like illness.

9 ied to historical data sets of patients with influenza-like illness.

10 and 95.6% specific (90.0-98.5) compared with influenza-like illness.

11 ontrols with community-acquired pneumonia or influenza-like illness.

12 lized adults older than 65 years of age with influenza-like illness.

13 and capacity preparedness for influenza and influenza-like illness.

14 duce the duration of hospital stay in severe influenza-like illness.

15 903) against acute respiratory infections or influenza-like illness.

16 tained from participants with symptoms of an influenza-like illness.

17 e and visited weekly to detect pneumonia and influenza-like illness.

18 test-negative design among outpatients with influenza-like illness.

19 n multiple occasions and 1 employee reported influenza-like illness.

20 as a proxy for complications of influenza or influenza-like illness.

21 rical baseline when forecasting incidence of influenza-like illness 1 wk, 2 wk, and 3 wk ahead of ava

22 Among 48 nonhospitalized children with influenza-like illness, 1 or more respiratory pathogens

23 nts assigned any dose of opicinumab included influenza-like illness (140 [43%] with any dose of opici

24 nd significantly shortened symptom duration (influenza-like illness, 82%; 95% CI, 39-95%).

25 Human monocytic ehrlichiosis, an influenza-like illness accompanied by signs of hepatitis

26 March 2020, cough, shortness of breath, and influenza-like illness accounted for twice as many ED vi

27 -analyses showed significantly lower odds of influenza-like illness after vaccination in patients wit

28 d one anaphylaxis) and one possibly related (influenza-like illness); all three recovered without seq

29 lude designating areas for waiting rooms for influenza-like illnesses, altering staff scheduling in a

30 on than standard-dose IIV4 against confirmed influenza-like illness among older adults.

31 In 1998, there was an outbreak of influenza-like illness among swine that was caused by A(

32 gs were related to the clinical incidence of influenza-like illness and acute bronchitis at that time

33 ing pathogen that causes rapidly progressing influenza-like illness and acute encephalitis often lead

34 Rt provided alarms for influenza-like illness and bronchiolitis epidemics that

35 rt had at least one adverse event, primarily influenza-like illness and chills.

36 ive in preventing total respiratory illness (influenza-like illness and clinically diagnosed pneumoni

37 2,595-428,286) attended 35,663 patients with influenza-like illness and collected 13,925 respiratory

38 inactivated influenza vaccine in preventing influenza-like illness and influenza-associated pneumoni

39 ocompromised patients in terms of preventing influenza-like illness and laboratory confirmed influenz

40 ated significant protective associations for influenza-like illness and laboratory-confirmed influenz

41 e probably associated with similar risks for influenza-like illness and laboratory-confirmed viral in

42 ngeal swabs were collected from persons with influenza-like illness and tested for influenza virus by

43 were hospitalized for at least 24 hours for influenza-like illness and who tested positive for the 2

44 Patients with influenza-like illness and/or positive rapid test result

45 Infection was defined as RTPCR+ influenza-like-illness and/or seroconversion.

46 fing and capacity responses to influenza and influenza-like illness, and (4) future staffing and capa

47 teen percent of household contacts developed influenza-like illness, and 10% of household contacts ha

48 rted in 3289 (28.7%) of 11,459 patients with influenza-like illness, and antivirals were prescribed t

49 ospitalized with pneumonia, outpatients with influenza-like illness, and asymptomatic control patient

50 Severe outcome included conjunctivitis, influenza-like illness, and one lethal infection.

51 percentage of outpatient doctors visits for influenza-like illness, and the season onset, duration,

52 We find that seasonal variations in climate, influenza-like illnesses, and interindividual contacts j

53 As many as 40% of patients hospitalized with influenza-like illness are reported to be infected with

54 to participating general practitioners with influenza-like illness are swabbed for laboratory testin

55 easons for the rapid and extensive spread of influenza-like illnesses are unknown.

56 bout preparedness for seasonal influenza and influenza-like illness as well as concerns about staffin

57 influenza illness, defined as development of influenza-like illness associated with influenza virus o

58 events were headache, fatigue, pyrexia, and influenza-like illness at 12 weeks (95 [37%) vs 45 [34%]

59 y specimens from outpatients presenting with influenza-like illness at 13 facilities in order to inve

60 participants >=1 year old hospitalized with influenza-like illness at 6 hospitals in Mexico.

61 boratory-confirmed influenza associated with influenza-like illness at least 14 days after vaccinatio

62 oint was RT-PCR-confirmed, protocol defined, influenza-like illness between 14 days or more after vac

63 y collected NPS specimens from patients with influenza-like illness between February 2008 and 28 May

64 hospital admissions related to pulmonary and influenza-like illness between Nov 1, 2013, and May 31,

65 ical versus no mask in risk for influenza or influenza-like illness, but compliance was low.

66 For the four influenza-like illness case definitions evaluated, all y

67 In this study, a total of 2,583,441 influenza-like illness cases tested from 2010 to 2017 in

68 action (RT-PCR)-confirmed, protocol-defined, influenza-like illness caused by any influenza strain st

69 We found no difference in the odds of influenza-like illness compared to vaccinated immunocomp

70 Vaccine effect was demonstrated for the influenza-like illness consultation outcome using the Co

71 a A/H3N2, A/H1N1, and B that combine data on influenza-like illness consultations and respiratory spe

72 fficacy attributes, and general practitioner influenza-like-illness consultations as reported by the

73 Active surveillance for influenza-like illnesses continued from days 14 to 385.

74 n either the community-acquired pneumonia or influenza-like illness controls.

75 dentify influenza and SARS-CoV-2 infections: influenza-like illness, coronavirus disease 2019-like il

76 Influenza-like illness data are collected via an Influen

77 These were combined with influenza-like illness data to derive measures of influe

78 respect to efficacy was laboratory-confirmed influenza-like illness (defined as a temperature of at l

79 If an influenza-like illness developed in one member, the fami

80 ataset of cell-phone users and their date of influenza-like illness diagnosis during the 2009 H1N1v p

81 f influenza is recommended for patients with influenza-like illness during periods of community cocir

82 and measured when they were symptomatic with influenza-like illness during the 2009 A/H1N1pdm influen

83 iously evaluated for respiratory symptoms or influenza-like illness during the first 10 weeks of 2020

84 tics, influenza vaccination, and outcomes of influenza-like illness during the previous 7 days.

85 of employee respondents) reported having an influenza-like illness during this period.

86 resented to general practices in the UK with influenza-like illnesses during three successive winters

87 from the first ten patients presenting with influenza-like illness each week.

88 muting flows and predict the diffusion of an influenza-like-illness epidemic.

89 Yearly bronchiolitis and influenza-like illness epidemics in France often involve

90 s an early-warning tool for bronchiolitis or influenza-like illness epidemics in France.

91 etected earlier signals of bronchiolitis and influenza-like illness epidemics.

92 with an 80% effective vaccine to prevent one influenza-like illness episode.

93 of influenza activity and the risk of acute influenza-like illness episodes among 8,323 healthy preg

94 We recorded 5279 influenza-like illness episodes in 2789 (68%) infants, o

95 f association between influenza exposure and influenza-like illness episodes increased as the pregnan

96 Influenza-like illness episodes were identified from med

97 The authors compared the occurrence of influenza-like illness episodes within each pregnancy st

98 e association between influenza activity and influenza-like illness episodes.

99 capable of detecting the temporal trends of influenza-like illness even without relying on a specifi

100 The most common adverse events were influenza-like illness, fatigue, anemia, and neutropenia

101 group had constitutional signs and symptoms (influenza-like illness, fatigue, fever, and chills) than

102 jurisdictions in the USA reported counts of influenza-like illness (fever including cough or sore th

103 We examined outpatients with influenza-like illness for HBoV infection and tested for

104 We report prospective influenza-like-illness forecasts made for the 2013-2014

105 We analyzed 31 years (1985-2016) of data on influenza-like illness from the French Sentinelles syste

106 swabs collected from patients in Wuhan with influenza-like-illness from 6 October 2019 to 21 January

107 e 2012 provided patient-level data on severe influenza-like-illnesses from >100 participating clinica

108 Emergency department visits for influenza-like illness, grouped by age (>/=0 years and >

109 s with confirmed 2009 H1N1 influenza or with influenza-like illness had severe symptoms.

110 s were mild-to-moderate injection-site pain, influenza-like illness, headache, and fatigue.

111 ystem for influenza that includes virologic, influenza-like illness, hospitalization, and mortality d

112 analyze the spatio-temporal distribution of Influenza Like Illness (ILI) in the city of Jerusalem ov

113 95% confidence interval [CI]:0.46-0.77) and influenza-like illness (ILI) (RR = 0.34; 95% CI:0.14-0.8

114 Influenza-like illness (ILI) activity has been associate

115 sed this ITS dataset to estimate and predict influenza-like illness (ILI) activity in the United Stat

116 Influenza-like illness (ILI) activity, provided by the O

117 of 9 donors developed symptoms consistent an influenza-like illness (ILI) and 7 of 9 were proven to b

118 Confirmed cases had influenza-like illness (ILI) and a positive laboratory t

119 gher incidence, duration, and/or severity of influenza-like illness (ILI) and acute respiratory infec

120 ss (SRI) at 2 hospitals and outpatients with influenza-like illness (ILI) and asymptomatic individual

121 enza A infection and either protocol-defined influenza-like illness (ILI) and Centers for Disease Con

122 Outpatients with influenza-like illness (ILI) and inpatients with severe

123 hospitals across the country, patients with influenza-like illness (ILI) and severe acute respirator

124 We conducted ISS by monitoring patients with influenza-like illness (ILI) and severe acute respirator

125 08, we established sentinel surveillance for influenza-like illness (ILI) and severe acute respirator

126 Callers were evaluated for symptoms of influenza-like illness (ILI) and were prescribed an anti

127 Dengue and influenza-like illness (ILI) are two of the leading caus

128 za surveillance for patients presenting with influenza-like illness (ILI) at 136 private and public c

129 (CDC) runs an annual competition to forecast influenza-like illness (ILI) at the regional and nationa

130 ests, confirmed cases) and weekly dengue and influenza-like illness (ILI) case counts, Delphi-RF deli

131 SV) surveillance is heavily dependent on the influenza-like illness (ILI) case definition from the Wo

132 ng laboratory-confirmed cases than syndromic influenza-like illness (ILI) cases.

133 ompile weekly reports based on the number of influenza-like illness (ILI) clinical cases observed amo

134 sing causal inference methods on 12 years of influenza-like illness (ILI) data and 2 decades of respi

135 National Laboratory Surveillance System, and influenza-like illness (ILI) data were collected from Da

136 The WHO influenza-like illness (ILI) definition was 16% sensitiv

137 imated whether in utero exposure to maternal influenza-like illness (ILI) during the 1918 pandemic wa

138 nd oropharyngeal swabs were collected during influenza-like illness (ILI) episodes and from controls.

139 rveillance in children <11 years old who had influenza-like illness (ILI) from January 2008 to Decemb

140 ory system for the syndromic surveillance of influenza-like illness (ILI) in Europe.

141 t-Kenya (USAMRU-K) conducts surveillance for influenza-like illness (ILI) in Kenya.

142 estimating, in near-real time, the level of influenza-like illness (ILI) in the United States (US) b

143 rto Rico from 1990 to 2009 and to reports of influenza-like illness (ILI) in the United States betwee

144 We test NobBS on dengue in Puerto Rico and influenza-like illness (ILI) in the United States to exa

145 Influenza-like illness (ILI) is a commonly measured synd

146 entral Hospital, Blantyre, and a prospective influenza-like illness (ILI) observational study between

147 Here, we investigated the effects of influenza-like illness (ILI) on pneumococcal carriage in

148 lthcare-seeking behaviors among persons with influenza-like illness (ILI) or adherence to influenza a

149 patients seen in the outpatient clinic with influenza-like illness (ILI) or hospitalized with severe

150 mized controlled trials (RCTs) had to report influenza-like illness (ILI) or infection rates amongst

151 RSV cases were infants who developed influenza-like illness (ILI) or pneumonia and were RSV-p

152 al (NP/OP) swab specimens from patients with influenza-like illness (ILI) or severe acute respiratory

153 We prospectively enrolled outpatients with influenza-like illness (ILI) presenting at 14 sentinel c

154 the state-of-the-art forecasting accuracy of influenza-like illness (ILI) rates in the United States.

155 ce for acute respiratory infection (ARI) and influenza-like illness (ILI) relies primarily on reports

156 n methods with Wikipedia access logs and CDC influenza-like illness (ILI) reports to create a weekly

157 We obtained influenza-like illness (ILI) surveillance data from 29 C

158 of schools closed within a district to state influenza-like illness (ILI) surveillance data, we measu

159 The goal of influenza-like illness (ILI) surveillance is to determin

160 We performed influenza-like illness (ILI) surveillance on 220 individ

161 Evaluating the usefulness of influenza-like illness (ILI) surveillance systems and de

162 ng behavior of FNY participants who reported influenza-like illness (ILI) symptoms.

163 ng behavior of FNY participants who reported influenza-like illness (ILI) symptoms.

164 atory symptoms not meeting ILI criteria) and influenza-like illness (ILI) to determine the incidence

165 tioners sent throat swabs from patients with influenza-like illness (ILI) to the National Institute f

166 rVE was estimated against influenza-like illness (ILI) using diagnostic Internatio

167 Estimation of influenza-like illness (ILI) using search trends activit

168 nfluenza vaccines LAIV and TIV in preventing influenza-like illness (ILI) was compared among US milit

169 Active surveillance for influenza-like illness (ILI) was conducted on 4455 child

170 onths to <10 years at first vaccination with influenza-like illness (ILI) was evaluated in Australia,

171 Influenza-like illness (ILI) was reported by 79 of 702 h

172 f samples taken from patients diagnosed with influenza-like illness (ILI) within the sentinel scheme

173 .3% against a febrile episode, 53.5% against influenza-like illness (ILI), 41.8% against related heal

174 However, the extent to which influenza-like illness (ILI), a syndrome comprising a ra

175 included GMTs to month 12, the incidence of influenza-like illness (ILI), and adverse reactions afte

176 s (GMTs), GMT ratios (GMRs), adverse events, influenza-like illness (ILI), and laboratory-confirmed i

177 icipatory surveillance data on self-reported influenza-like illness (ILI), defined here as self-repor

178 ation records, and healthcare encounters for influenza-like illness (ILI), influenza, and pneumonia a

179 percent of influenza-positive patients with influenza-like illness (ILI), or severe acute respirator

180 tified 89 HCWs and 18 inpatients as cases of influenza-like illness (ILI), using an amended definitio

181 ry pathogens in individuals >/=65 years with influenza-like illness (ILI).

182 ter within 3 days of donation complaining of influenza-like illness (ILI).

183 ms of respiratory viral infection, including influenza-like illness (ILI).

184 ks and hand hygiene reduced the incidence of influenza-like illness (ILI).

185 pitalization rates and outpatient visits for influenza-like illness (ILI).

186 he use of search data to track prevalence of Influenza-Like Illness (ILI).

187 (RSV) infections in adults hospitalized with influenza-like illness (ILI).

188 ould identify outliers in influenza-negative influenza-like illness (ILI).

189 ase chain reaction (PCR) for those reporting influenza-like illness (ILI).

190 use forecasts of key metrics associated with influenza-like illness (ILI); near-term weekly incidence

191 articipants received weekly surveys querying influenza-like illness (ILI); those reporting ILI comple

192 the difference in the rates of self-reported influenza-like illness (ILI, defined as presence of feve

193 uration of URTI and its composite syndromes, influenza-like illness (ILI; fever and >/=2 of sore thro

194 contribution consists of combining multiple influenza-like illnesses (ILI) activity estimates, gener

195 res (GMT), GMT ratios (GMR), adverse events, influenza-like-illness (ILI) and laboratory-confirmed in

196 Here, we define and analyze influenza-like-illness (ILI) case data from 2009-2010 fo

197 RSV cases were infants who developed influenza-like-illness (ILI) or pneumonia and were RSV p

198 Households (270) participated in influenza-like-illness (ILI) surveillance and provided b

199 surrogates for clinically-based reporting of influenza-like-illness (ILI).

200 maceutical sales and volume of patients with influenza-like-illnesses (ILI) at an urgent care center

201 gated the spatiotemporal association between influenza-like illnesses (ILIs) and licensed swine opera

202 se of acute histoplasmosis was defined as an influenza-like illness in a plant employee with the onse

203 ge numbers of Google search queries to track influenza-like illness in a population.

204 tamivir for treatment of naturally occurring influenza-like illness in adults reporting at least one

205 ta were collected from walk-in patients with influenza-like illness in Egypt during routine influenza

206 Recent reports of mild to severe influenza-like illness in humans caused by a novel swine

207 ), a virus sensed by STING that can cause an influenza-like illness in humans.

208 from children in a pediatric cohort study of influenza-like illness in Managua, Nicaragua, between Ju

209 lymerase chain reaction (PCR) to undiagnosed influenza-like illness in New York State led to the disc

210 primary outcomes: the incidence of maternal influenza-like illness in pregnancy and 0-180 days postp

211 tients aged 1 year and older presenting with influenza-like illness in primary care.

212 roportion of specimens from outpatients with influenza-like illness in the community that tested posi

213 m children aged 24-59 months presenting with influenza-like illness in The Gambia were collected duri

214 s well tolerated, but more patients reported influenza-like illness in the hydroxychloroquine group c

215 imately, 25 to 50 million people suffer from influenza-like illness in the United States annually, le

216 012 during population-based surveillance for influenza-like illness in two rural provinces.

217 We also find evidence that influenza-like illnesses increase the invasion rate in a

218 We present temporal data on influenza-like illness, influenza diagnosis, and COVID-1

219 immunisation significantly reduced maternal influenza-like illness, influenza in infants, and low bi

220 d adult caregivers self-triage children with influenza-like illness is feasible.

221 visited weekly until age 6 months to detect influenza-like illness; laboratory-confirmed influenza d

222 ntly prescribed in European primary care for influenza-like illness, mostly because of perceived inef

223 f SARS-CoV-2 (n = 224) and of non-SARS-CoV-2 influenza-like illness (n = 184), and laboratory-confirm

224 the 2009 H1N1 pandemic, with an increase in influenza-like illnesses observed as early as August.

225 elevated percentage of outpatient visits for influenza-like illness occurred an average of 14 days af

226 Seven cases of culture-confirmed CDC-defined influenza-like illness occurred in 153 placebo recipient

227 ract infection, urinary tract infection, and influenza-like illness occurred in only 26, 9, and 7 ret

228 es showed a significant effect of preventing influenza-like illness (odds ratio [OR]=0.23; 95% confid

229 A total of 417 adults with influenza-like illness of < or =48 hours' duration were

230 ly healthy non-immunised adults with febrile influenza-like illness of up to 36 h duration.

231 Here we quantified the impact of influenza-like illness on social mixing patterns.

232 tion of strain, (2) effects of influenza and influenza-like illness on staff and patient care, (3) im

233 ed, but the specific effect of influenza and influenza-like illnesses on triggering acute myocardial

234 nal pain (one [7%]), fatigue (one [7%]), and influenza-like illness (one [7%]) in three patients trea

235 ing to a sentinel physician within 7 days of influenza-like illness onset.

236 ties in Addis Ababa met case definitions for influenza-like illness or severe acute respiratory illne

237 ng 2010 from inpatients and outpatients with influenza-like illness or severe acute respiratory illne

238 es without swine exposure were identified in influenza-like illness outbreaks, indicating that limite

239 We simulate an influenza-like illness over the contact network to evalu

240 he original model significantly mispredicted influenza-like illness rates in the US during the 2012-1

241 ment to usual primary care for patients with influenza-like illness reduces time to recovery overall

242 r subtype associated with a protocol-defined influenza-like illness (relative efficacy, 24.2%; 95% co

243 t of Columbia, using a combination of excess influenza-like illness reports, COVID-19 test statistics

244 For example, "influenza-like illness"-routinely monitored as a proxy f

245 In 4124 samples from individuals with influenza-like illness, SARS-CoV-2 was identified in 583

246 7%] of 54 patients), headache (eight [15%]), influenza-like illness (seven [13%]), and an increase in

247 received ABI-H0731 were headache (11 [15%]), influenza-like illness (seven [9%]), and dizziness (six

248 We conducted sentinel surveillance for influenza-like illness, severe acute respiratory illness

249 prompt evaluation and antiviral treatment of influenza-like illness should be considered in such wome

250 Centers for Disease Control and Prevention's influenza-like illness surveillance data with aggregated

251 ease Control and Prevention (CDC) Outpatient Influenza-like Illness Surveillance Network and Centers

252 s (ILI) activity, provided by the Outpatient Influenza-like Illness Surveillance Network of the Cente

253 270 households participated in influenza-like-illness surveillance and provided blood a

254 n applied to redesigning the provider-based, influenza-like-illness surveillance network (ILINet) for

255 s of infected children (<19 years) displayed influenza-like illness symptoms than infected adults (re

256 had acute respiratory symptoms, and 62% had influenza-like illness symptoms.

257 first symptomatic person in a household with influenza-like illness, testing influenza positive on re

258 s had twice the risk of developing secondary influenza-like illness than contacts of HIV-negative ind

259 g winter 2004, there was a high incidence of influenza-like illness that tested negative both for inf

260 In individuals diagnosed with influenza-like illness, there is a substantial potential

261 infection ranges in disease severity from an influenza-like illness to life-threatening shock.

262 center of attention from the first signs of influenza-like illness to recovery.

263 Primary care patients with influenza-like illness treated with oseltamivir recovere

264 We calculated the incidence of visits for influenza-like illness using the size of the patient pop

265 The probability of influenza-like illness was 30% lower with RIV4 than with

266 as compared with the control vaccine against influenza-like illness was 34.5% (95% confidence interva

267 Weekly telephone surveillance for influenza-like illness was conducted during the influenz

268 nasopharyngeal swabs from participants with influenza-like illness was confirmed by reverse-transcri

269 No influenza-like illness was developed and no H3N8 RNA was

270 e and the use of aspirin during varicella or influenza-like illness was first reported, there has bee

271 Influenza-like illness was monitored with cultures throu

272 os across trials for all-cause mortality and influenza-like illness were 0.71 (95% confidence interva

273 Emergency department visits for influenza-like illness were associated with and predicti

274 influenza was circulating and those coded as influenza-like illness were associated with consistently

275 Cases of influenza-like illness were caused by A/H3N2 and A/H1N1

276 Specimens from patients presenting with influenza-like illness were collected and shipped to the

277 he 2010-2011 influenza season, subjects with influenza-like illness were enrolled in an emergency dep

278 Nonhospitalized UC with influenza-like illness were interviewed, and nasopharyng

279 Most outcomes related to influenza-like illness were significantly lower in inter

280 ute respiratory illness and outpatients with influenza-like illness were tested by real-time reverse

281 ospitals and primary healthcare centers with influenza-like illness were tested for influenza from th

282 Patients attended with influenza-like illness were tested for influenza.

283 Nose and throat samples obtained during influenza-like illnesses were tested for A/California/7/

284 cted specimens from patients presenting with influenza-like illness who visited sentinel surveillance

285 C) runs a challenge for forecasting weighted influenza-like illness (wILI) at the national and region

286 Immunisation reduced maternal febrile influenza-like illness with an overall efficacy of 19% (